相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Inhibition of c-Myc using 10058-F4 induces anti-tumor effects in ovarian cancer cells via regulation of FOXO target genes
Roya Ghaffarnia et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Gemcitabine inhibits cisplatin resistance in cisplatin-resistant A549 cells by upregulating trx-interacting protein and inducing cell cycle arrest
Wenjie Cao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers
Yiting Chen et al.
FRONTIERS IN ONCOLOGY (2020)
Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status
Davood Bashash et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
Ana C. Garrido-Castro et al.
CANCER DISCOVERY (2019)
ROS and the DNA damage response in cancer
Upadhyayula Sai Srinivas et al.
REDOX BIOLOGY (2019)
Triple-negative breast cancer: current perspective on the evolving therapeutic landscape
Joe Mehanna et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2019)
Downregulation of TXNIP leads to high proliferative activity and estrogen-dependent cell growth in breast cancer
Jun Won Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer
Naveen K. R. Chalakur-Ramireddy et al.
BIOSCIENCE REPORTS (2018)
DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer
Yunxiao Meng et al.
CANCER LETTERS (2018)
Triple negative breast cancer in Asia: An insider's view
Chao Wang et al.
CANCER TREATMENT REVIEWS (2018)
Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication
Sanaz Nasoohi et al.
MOLECULAR NEUROBIOLOGY (2018)
TLR4/NF-kappa B axis induces fludarabine resistance by suppressing TXNIP expression in acute myeloid leukemia cells
Hangsak Huy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
TXNIP mediates the differential responses of A549 cells to sodium butyrate and sodium 4-phenylbutyrate treatment
Xuefang Jin et al.
CANCER MEDICINE (2017)
Anti-tumor effect of polysaccharide from Hirsutella sinensis on human non-small cell lung cancer and nude mice through intrinsic mitochondrial pathway
Wen-Bin Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
TXNIP overexpression suppresses proliferation and induces apoptosis in SMMC7221 cells through ROS generation and MAPK pathway activation
Jian Li et al.
ONCOLOGY REPORTS (2017)
Bicyclol exerts an anti-tumor effect via ROS-mediated endoplasmic reticulum stress in human renal cell carcinoma cells
Jing Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Thioredoxin-interacting protein regulates haematopoietic stem cell ageing and rejuvenation by inhibiting p38 kinase activity
Haiyoung Jung et al.
NATURE COMMUNICATIONS (2016)
Targeting c-MYC in Platinum-Resistant Ovarian Cancer
Jeyshka M. Reyes-Gonzalez et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP
Liangliang Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Thioredoxin-Interacting Protein: Pathophysiology and Emerging Pharmacotherapeutics in Cardiovascular Disease and Diabetes
Cher-Rin Chong et al.
CARDIOVASCULAR DRUGS AND THERAPY (2014)
Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma
James P. Hamilton et al.
HEPATOLOGY RESEARCH (2014)
Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells
Jiandong Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Minireview: Thioredoxin-Interacting Protein: Regulation and Function in the Pancreatic β-Cell
Anath Shalev
MOLECULAR ENDOCRINOLOGY (2014)
High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
Yan Ma et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer
Ke-Da Yu et al.
CLINICAL CANCER RESEARCH (2013)
MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors
Aatur D. Singhi et al.
MODERN PATHOLOGY (2012)
Prolonged expression of the γ-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment
Emma C. Bourton et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells
Che-Pin Lin et al.
ANTI-CANCER DRUGS (2007)
A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia
Ming-Jer Huang et al.
EXPERIMENTAL HEMATOLOGY (2006)
Does γH2AX foci formation depend on the presence of DNA double strand breaks?
A Takahashi et al.
CANCER LETTERS (2005)
VDUP1 upregulated by TGF-β1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression
SH Han et al.
ONCOGENE (2003)
分享论文
